Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling

Neoplasia

Volumn 13, Issue 9, 2011, Pages 874-886

  Margolin, David A ^a   Silinsky, Jennifer ^a   Grimes, Chelsea ^a   Spencer, Nakia ^a   Aycock, Melissa ^a   Green, Heather ^a   Cordova, Jose ^a   Davis, Nancy K ^a   Driscoll, Tiffany ^a   Li, Li ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FLUOROURACIL; OXALIPLATIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL ISOLATION; CELL SELECTION; CLINICAL ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TARGETING; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPH NODE STROMA CELL; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; STROMA CELL; TUMOR CELL; TUMOR GROWTH; TUMOR INITIATING CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 80053442440     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11324     Document Type: Article

References (42)

1. Jemal A, Siegel R, Xu J, and Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277-300.
2. Reya T, Morrison SJ, Clarke MF, and Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
3. Todaro M, Francipane MG, Medema JP, and Stassi G (2010). Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138, 2151-2162.
4. SEER Cancer Statistics Review. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed April 18, 2011.
5. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW Jr, de la Chapelle A, and Frankel WL (2004). Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23, 7366-7377.
6. Kouniavsky G, Khaikin M, Zvibel I, Zippel D, Brill S, Halpern Z, and Papa M (2002). Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines. Clin Exp Metastasis 19, 55-60.
7. Madlambayan GJ, Butler JM, Hosaka K, Jorgensen M, Fu D, Guthrie SM, Shenoy AK, Brank A, Russell KJ, Otero J, et al. (2009). Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood 114, 4310-4319.
8. Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, and Ratajczak MZ (2005). Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879-894.
9. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, and Hoon DS (2005). Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23, 2744-2753.
10. Zeelenberg IS, Ruuls-Van Stalle L, and Roos E (2003). The chemokine receptorb CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63, 3833-3839.
11. Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gonner U, Wilsberg V, Junginger T, Berger MR, Galle PR, and Moehler M (2005). Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11, 1743-1750.
12. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, and Heeschen C (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323.
13. Kim HS, Zhang X, Klyushnenkova E, and Choi YS (1995). Stimulation of germinal center B lymphocyte proliferation by an FDC-like cell line, HK. J Immunol 155, 1101-1109.
14. Hu Y and Smyth GK (2009). ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347, 70-78.
15. Picard O, Rolland Y, and Poupon MF (1986). Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res 46, 3290-3294.
16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, and De Maria R (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115.
17. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, et al. (2008). CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14, 6751-6760.
18. O'Brien CA, Pollett A, Gallinger S, and Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
19. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, and Jung A (2009). The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 219, 427-434.
20. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, and Mori M (2008). CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15, 2927-2933.
21. Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G II, Samuel S, Kim MP, Lim SJ, and Ellis LM (2009). Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69, 1951-1957.
22. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, et al. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203, 2201-2213.
23. Teicher BA and Fricker SP (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16, 2927-2931.
24. Kim HS, Zhang X, and Choi YS (1994). Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes. J Immunol 153, 2951-2961.
25. Li L and Choi YS (2002). Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells. Semin Immunol 14, 259-266.
26. Li L, Yoon SO, Fu DD, Zhang X, and Choi YS (2004). Novel follicular dendritic cell molecule, 8D6, collaborates with CD44 in supporting lymphomagenesis by a Burkitt lymphoma cell line, L3055. Blood 104, 815-821.
27. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
28. Li CY, Li BX, Liang Y, Peng RQ, Ding Y, Xu DZ, Zhang X, Pan ZZ, Wan DS, Zeng YX, et al. (2009). Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J TranslMed 7, 56.
29. - metastatic colon cancer cells initiate tumors. J Clin Invest 118, 2111-2120.
30. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al. (2010). Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12, 468-476.
31. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104, 10158-10163.
32. Saiki Y, Ishimaru S, Mimori K, Takatsuno Y, Nagahara M, Ishii H, Yamada K, and Mori M (2009). Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 16, 2638-2644.
33. Hostettler L, Zlobec I, Terracciano L, and Lugli A (2010). ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol 16, 732-739.
34. Husson H, Carideo EG, Cardoso AA, Lugli SM, Neuberg D, Munoz O, de Leval L, Schultze J, and Freedman AS (2001). MCP-1 modulates chemotaxis by follicular lymphoma cells. Br J Haematol 115, 554-562.
35. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, Nakano K, Itami A, Kawada K, Nagayama S, et al. (2009). Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 16, 2645-2653.
36. Dessein AF, Stechly L, Jonckheere N, Dumont P, Monte D, Leteurtre E, Truant S, Pruvot FR, Figeac M, Hebbar M, et al. (2010). Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70, 4644-4654.
37. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R, Beider, Avniel S, Kasem S, Galun E, et al. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 18, 1240-1242.
38. Dick JE (2008). Stem cell concepts renew cancer research. Blood 112, 4793-4807.
39. Visvader JE and Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev 8, 755-768.
40. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, and Weinberg RA (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101, 4966-4971.
41. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, et al. (2008). Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3, e2428.
42. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, et al. (2007). Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389-402.